Mumbai: GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma) has received a tax demand of Rs 23.21 crore from the Income Tax Department following a scrutiny assessment for the Assessment Year 2023-24.The order,…
New Delhi: Sun Pharmaceutical Industries Limited has announced that it will present 14 scientific abstracts highlighting advances in alopecia areata, psoriasis, and acne research at the 2026 American Academy of…
Kolkata: The West Bengal University of Health Sciences (WBUHS) has issued a notification announcing the extension of the registration deadline for BSc Nursing students for the 2025-2026 academic batch. The…
New Delhi: Through a recently released amended Minimum Standards of Requirements for Post Graduate Courses 2023 (PGMSR-2023), the National Medical Commission (NMC) has notified requirements regarding clinical workload, diagnostic facilities…
London: Swiss drugmaker Novartis said on Friday it will buy California-based biotech company Excellergy in a deal worth up to USD 2 billion, the second sizeable acquisition it has announced…
Bengaluru: French drugmaker Sanofi said on Friday the European Medicines Agency has recommended the approval of a subcutaneous version of its blood cancer drug administered through an on-body injector.EMA's positive…
New Delhi: Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary endpoints while further trials and regulatory pathways continue to…
New Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Paroxetine Extended-Release Tablets USP, 12.5 mg, strengthening its portfolio in the…
New Delhi: Hetero has announced the export launch of its generic semaglutide portfolio, marking a significant step toward expanding access to GLP-1 therapies for the treatment of type 2 diabetes…
Bengaluru: Biocon Limited today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the Nomination & Remuneration Committee…